Connor, Clark & Lunn Investment Management (CC&L)’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.42M | Sell |
|
|||||
|
2023
Q1 | $1.82M | Sell |
|
|||||
|
2022
Q4 | $1.29M | Sell |
|
|||||
|
2022
Q3 | $1.21M | Buy |
|
|||||
|
2022
Q2 | $271K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $68K | Sell |
|
|||||
|
2020
Q1 | $246K | Buy |
|
|||||
|
2019
Q4 | $520K | Buy |
|
|||||
|
2019
Q3 | $407K | Sell |
|
|||||
|
2019
Q2 | $575K | Buy |
|
|||||
|
2019
Q1 | $741K | Buy |
|
|||||
|
2018
Q4 | $392K | Buy |
|